At Hoth Therapeutics, Inc. (NASDAQ: HOTH), we strive to develop innovative, impactful, and ground-breaking treatments with a goal to improve patient quality of life. We are a catalyst in early-stage pharmaceutical research and development, elevating promising drugs from the bench to pre-clinical and clinical testing. Utilizing a patient-centric approach, we collaborate and partner with a team of scientists, clinicians, and key opinion leaders to seek out and investigate medications that hold immense potential to create breakthroughs and diversify treatment options.
Company Details
- Employees
- 8
- Founded
- -
- Address
- One Rockefeller Plaza, 10th Fl, New York,ny 10020,united States
- Industry
- Biotechnology
- Website
- hoththerapeutics.com
- Keywords
- Oncology, Dermatology, Neurology, Cardiovascular, Inflammatory, Alzheimer's Disease, Traumatic Brain Injury, Acne, Eczema, Mast-Cell Derived Cancers, IBDs, Ischemic Stroke, Skin Toxicities, Cancer Therapies.
- HQ
- New York, NY
Hoth Therapeutics, Inc Questions
Hoth Therapeutics, Inc's website is hoththerapeutics.com
Hoth Therapeutics, Inc's LinkedIn profile is https://www.linkedin.com/company/hoth-therapeutics-inc
Hoth Therapeutics, Inc has
8 employees.
View email and phone details for 8
employees at Hoth Therapeutics, Inc.
Hoth Therapeutics, Inc's industry is
Biotechnology
Hoth Therapeutics, Inc's top competitors are
Orsobio,
Sentynl Therapeutics, Inc.,
Vaxcyte,
Tenvie Therapeutics,
Athira Pharma,
Travere Therapeutics,
In8bio,
Arsenal Biosciences, Inc.,
Emergent Biosolutions,
Lykos Therapeutics.
Hoth Therapeutics, Inc's categories are Biotechnology
Hoth Therapeutics, Inc's founding year is 2017
